Zhang Jun-ping, Lu Shi-chao, Yuan Zhuo
The First Hospital Affiliated to Tianjin University of Traditional Chinese Medicine, Tianjin 300193.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Jul;31(7):985-7.
Along with the extensive application of intervention in treating coronary heart disease (CHD), problems such as post-interventional restenosis, no reflowing, and slow flowing, and so on increasingly emerge. Chinese medicine and pharmacy occupy advantages covering preventing post-intervention risk factors, improving and relieving patients' symptoms, and so on. It is a good support and supplement for routine therapies in modern medicine. Taking the pathological stages of CHD and clinical problems of coronary intervention as the breakthrough points, the Chinese medical syndromes and correspondent Chinese medicine recipes and herbs were preliminarily studied by combining Chinese medicine's recognition and clinical observation on coronary intervention.
随着冠心病（CHD）介入治疗的广泛应用，介入后再狭窄、无复流、慢血流等问题日益凸显。中医药在干预冠心病介入后危险因素、改善和缓解患者症状等方面具有优势，是现代医学常规治疗的良好支持与补充。以冠心病的病理阶段和冠脉介入的临床问题为切入点，结合中医对冠脉介入的认识及临床观察，对冠心病中医证候及相应的中药方剂、中药进行了初步研究。
